Connected Drug Delivery Devices Market Analysis By Product Type(Standalone Components & Software, Integrated Devices), By Route of Administration(Parenteral, Inhalational), By Application(Asthma, COPD, Diabetes Management), By Technology(Bluetooth, NFC), By End User(Homecare, Hospitals) & Forecast 2024-2035
- PUBLISHED ON
- 1/12/2023
- NO OF PAGES
- 225
- CATEGORY
- Healthcare & Life Sciences
In 2021, the market for Global Connected Drug Delivery Devices worldwide was worth $0.31 billion US dollars. AMR Group projects that the market will reach US$ 1.9 billion by 2031, growing at a CAGR of 21.3 percent between 2022 and 2031.
Industry Overview
Connected drug delivery devices are machines that deliver various medicinal agents into a patient's body in order supply medical treatment and monitor the patient's condition. These devices are used to help minimize noncompliance with medication prescriptions and to provide better health care. In residential areas, smart wireless electronic systems known as connected drug delivery devices are utilized to support patient monitoring and counselling. Sensors, adherence trackers, dose reminders, and monitoring systems provide real-time feedback and educational materials for individualized patient care. They are more convenient and less expensive than clinic therapies. As a result, connected drug delivery devices are frequently used in the remote monitoring of patients with conditions such as diabetes, asthma, hepatitis C, hypertension, multiple sclerosis, tuberculosis, clinically isolated disorder, Chronic Obstructive Pulmonary Disease (COPD), and recipients of kidneys and liver transplants. It has been found that connected drug delivery devices can enable physicians monitor patient compliance with their recommended therapy and modify a patient's treatment as necessary. The acceptance of connected drug delivery devices is expected to be amplified by a rise in efforts to educate people about the complications caused by medication under or overdosing.
Connected drug delivery devices combine features like access to a variety of online services. Many market players are developing devices to aid in enhanced care monitoring and therapy. Many connected drug delivery systems involve adherence monitors, drug reminders, patient records to gather health information, and patient education opportunities. These devices are commonly used to treat asthma, COPD, diabetes, and other cardiovascular diseases. Because of rising rates of asthma, COPD, and diabetes, the Connected Drug Delivery Devices Market is expected to grow throughout the forecast period, providing a lucrative opportunity for increased use of connected drug delivery devices and increased market revenue.
Market Dynamics
The rapidly growing cost of medical management, as well as the growing need to improve patient treatment outcomes, are driving demand for connected drug delivery devices. In addition, a shift in preferences toward home-based care is fueling market growth. Furthermore, the growing number of people suffering from chronic diseases, combined with a greater emphasis on preventive care, is positively influencing the market. Furthermore, the widespread use of connected devices in laboratories and hospitals for the maintenance of Electronic Health Records (EHR) is expected to drive market growth.
The increased R&D activities are a key market driver. It also contributes to an exponential growth rate due to the robust product pipeline of several key players, which is expected to be commercially launched during the forecast period. In May 2021, for example, Eli Lilly and Company collaborated with four companies - DexCom, Inc., Glooko Inc., Roche, and myDiabby Healthcare to develop connected solutions for diabetics in markets outside of the United States. The companies' diabetes management platforms are expected to be complementary with Lilly's Tempo Pen and Tempo Smart Button to help diabetes patients, thereby propelling market growth. However, the patient treatments data security is the major risk related to connected delivery device solutions which could reduce the market revenue during the anticipated period.
COVID Impact
The Connected Drug Delivery Devices market has shown a positive impact during the COVID-19 pandemic period. The market, increased provider and patient awareness of connected devices, adoption, and the importance of remote monitoring for medication adherence. Adherium Limited, a key respiratory eHealth company, for example, reported COVID-driven acceleration in remote patient monitoring across the globe in 2021. However, the company encountered difficulties in moving forward with planned pilot evaluations with partners in the United States due to the pandemic. Due to the relaxation of movement restrictions and improved hospital access, the company anticipates a strong series of positive commercial and R&D activities in 2022.
Regional Trend
Geographically, the global Connected Drug Delivery Devices market is segmented into North America, Latin America, Asia Pacific, Europe, and Middle East & Africa. North America is dominating the largest share of the global Connected Drug Delivery Devices market with a share of 30% in 2021. North America holds the highest market share due to the region’s high per capita healthcare spending, rapid adoption of technology presence of key players, and growing adoption of remote monitoring for medication adherence. Moreover, Asia Pacific is lined up to register the fastest growth at a rate of over 24% during the forecast period. The growing number of companies and initiatives deployed by them is expected to fuel regional growth in the Asia-Pacific market. Adherium, for example, is a public company based in New Zealand that focuses on developing solutions for remote monitoring, patient adherence, and data management in the respiratory field.
Competitive Landscape
Key players operating in the global tissue diagnostics market are 3M, Adherium Limited, Antares Pharma, AptarGroup Inc., Bayer AG, BD, BioCorp, Cipla Inc., Cohero Health, Inc., Enable Injections, F. Hoffmann-La Roche Ltd, Gerresheimer AG, GlaxoSmithKline plc, Insulet Corporation, Johnson & Johnson Services, Inc., MEDMIX SYSTEMS AG, Medtronic, Merck & Co., Inc., Novartis AG, Novo Nordisk A/S, Novosanis, OraSure Technologies, Inc., Pfizer Inc., Phillips-Medisize, LLC, Propeller Health, Proteus Digital Health, Sanofi, SMC Ltd., Sulzer Ltd, Syncro Technology Corp., Tandem Diabetes Care, Inc., Teva Respiratory, LLC, ViVO Smart Medical Devices Ltd., West Pharmaceutical Services, Inc., and Ypsomed AG among others. Roche signed a joint development agreement with Ibex Medical Analytics, a global leader in AI-based cancer diagnostics, in October 2021. They will collaborate to develop an embedded image analysis workflow for pathologists to seamlessly access to securely exchange data, Ibex's AI algorithms, insights, and decision support tools using Navify Digital Pathology, the cloud version of uPath enterprise software.
Key USP’s-
Remote monitoring and telehealth are quickly emerging as new, complementary standards of care. Continuous expansion of telehealth and remote monitoring services, particularly for respiratory disease products, is critical for lowering health-care costs while improving patient management.
Market Segmentation
Based upon the Product Type used in Connected Drug Delivery Devices Market is segmented into two segments of Standalone Components & Software and Integrated Devices in the drug delivery process. Based on Route of Administration, the Connected Drug Delivery Devices Market is segmented into Parenteral and Inhalational. Based on Application, the Connected Drug Delivery Devices Market is segmented into Asthma, COPD and Diabetes Management. Based on Technology, the Connected Drug Delivery Devices Market is segmented into Bluetooth, NFC and Others.
End user segment of Connected Drug Delivery Devices market is further classified into Homecare and Hospitals. The increasing healthcare expenditure is some of the major factors driving the growth of this segment.
By Product Type
· Standalone Components & Software
· Integrated Devices
By Route of Administration
· Parenteral
· Inhalational
By Application
· Asthma
· COPD
· Diabetes Management
By Technology
· Bluetooth
· NFC
· Others
By End User
· Homecare
· Hospitals
Global Connected Drug Delivery Devices Market: Regional Analysis
The countries covered in the regional analysis of the Global Connected Drug Delivery Devices market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.
Key Benefits:
• The analysis provides an overview of the factors driving and limiting the growth of the market including trends, structure and others.
• Market estimation for type and geographic segments is derived from the current market scenario and expected market trends.
• Porter’s Five Force Model and SWOT analysis are used to study the global Connected Drug Delivery Devices market and would help stakeholders make strategic decisions.
• The analysis assists in understanding the strategies adopted by the companies for the growth of this market.
• In-depth analysis of the types of Connected Drug Delivery Devices would help in identifying future applications in this market.
Reasons to Purchase this Report:
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Objectives of the Study:
• To provide with an exhaustive analysis on the Connected Drug Delivery Devices Market by Product, By Application, By End User and by Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
Historic Year: 2016-2022
Forecast: 2024-2035
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Connected Drug Delivery Devices Revenue
1.4 Market Analysis by Type
1.4.1 Global Connected Drug Delivery Devices Market Size Growth Rate by Type: 2023 VS 2032
1.4.2 Inhalation Devices
1.4.3 Injectable Devices
1.5 Market by Application
1.5.1 Global Connected Drug Delivery Devices Market Share by Application: 2023-2032
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Home Care
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Connected Drug Delivery Devices Market
1.8.1 Global Connected Drug Delivery Devices Market Status and Outlook (2017-2032)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Connected Drug Delivery Devices Production Capacity Market Share by Manufacturers (2017-2022)
2.2 Global Connected Drug Delivery Devices Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Connected Drug Delivery Devices Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Connected Drug Delivery Devices Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Connected Drug Delivery Devices Sales Volume Market Share by Region (2017-2022)
3.2 Global Connected Drug Delivery Devices Sales Revenue Market Share by Region (2017-2022)
3.3 North America Connected Drug Delivery Devices Sales Volume
3.3.1 North America Connected Drug Delivery Devices Sales Volume Growth Rate (2017-2022)
3.3.2 North America Connected Drug Delivery Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.4 East Asia Connected Drug Delivery Devices Sales Volume
3.4.1 East Asia Connected Drug Delivery Devices Sales Volume Growth Rate (2017-2022)
3.4.2 East Asia Connected Drug Delivery Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.5 Europe Connected Drug Delivery Devices Sales Volume (2017-2022)
3.5.1 Europe Connected Drug Delivery Devices Sales Volume Growth Rate (2017-2022)
3.5.2 Europe Connected Drug Delivery Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.6 South Asia Connected Drug Delivery Devices Sales Volume (2017-2022)
3.6.1 South Asia Connected Drug Delivery Devices Sales Volume Growth Rate (2017-2022)
3.6.2 South Asia Connected Drug Delivery Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.7 Southeast Asia Connected Drug Delivery Devices Sales Volume (2017-2022)
3.7.1 Southeast Asia Connected Drug Delivery Devices Sales Volume Growth Rate (2017-2022)
3.7.2 Southeast Asia Connected Drug Delivery Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.8 Middle East Connected Drug Delivery Devices Sales Volume (2017-2022)
3.8.1 Middle East Connected Drug Delivery Devices Sales Volume Growth Rate (2017-2022)
3.8.2 Middle East Connected Drug Delivery Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.9 Africa Connected Drug Delivery Devices Sales Volume (2017-2022)
3.9.1 Africa Connected Drug Delivery Devices Sales Volume Growth Rate (2017-2022)
3.9.2 Africa Connected Drug Delivery Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.10 Oceania Connected Drug Delivery Devices Sales Volume (2017-2022)
3.10.1 Oceania Connected Drug Delivery Devices Sales Volume Growth Rate (2017-2022)
3.10.2 Oceania Connected Drug Delivery Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.11 South America Connected Drug Delivery Devices Sales Volume (2017-2022)
3.11.1 South America Connected Drug Delivery Devices Sales Volume Growth Rate (2017-2022)
3.11.2 South America Connected Drug Delivery Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.12 Rest of the World Connected Drug Delivery Devices Sales Volume (2017-2022)
3.12.1 Rest of the World Connected Drug Delivery Devices Sales Volume Growth Rate (2017-2022)
3.12.2 Rest of the World Connected Drug Delivery Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
4 North America
4.1 North America Connected Drug Delivery Devices Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Connected Drug Delivery Devices Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Connected Drug Delivery Devices Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Connected Drug Delivery Devices Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Connected Drug Delivery Devices Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Connected Drug Delivery Devices Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Connected Drug Delivery Devices Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Connected Drug Delivery Devices Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Connected Drug Delivery Devices Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Connected Drug Delivery Devices Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Connected Drug Delivery Devices Sales Volume Market Share by Type (2017-2022)
14.2 Global Connected Drug Delivery Devices Sales Revenue Market Share by Type (2017-2022)
14.3 Global Connected Drug Delivery Devices Sales Price by Type (2017-2022)
15 Consumption Analysis by Application
15.1 Global Connected Drug Delivery Devices Consumption Volume by Application (2017-2022)
15.2 Global Connected Drug Delivery Devices Consumption Value by Application (2017-2022)
16 Company Profiles and Key Figures in Connected Drug Delivery Devices Business
16.1 Bayer AG
16.1.1 Bayer AG Company Profile
16.1.2 Bayer AG Connected Drug Delivery Devices Product Specification
16.1.3 Bayer AG Connected Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.2 Propeller Health
16.2.1 Propeller Health Company Profile
16.2.2 Propeller Health Connected Drug Delivery Devices Product Specification
16.2.3 Propeller Health Connected Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.3 West Pharmaceutical Services, Inc
16.3.1 West Pharmaceutical Services, Inc Company Profile
16.3.2 West Pharmaceutical Services, Inc Connected Drug Delivery Devices Product Specification
16.3.3 West Pharmaceutical Services, Inc Connected Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.4 3M Company
16.4.1 3M Company Company Profile
16.4.2 3M Company Connected Drug Delivery Devices Product Specification
16.4.3 3M Company Connected Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.5 OPKO Health
16.5.1 OPKO Health Company Profile
16.5.2 OPKO Health Connected Drug Delivery Devices Product Specification
16.5.3 OPKO Health Connected Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.6 Sagentia (Science Group)
16.6.1 Sagentia (Science Group) Company Profile
16.6.2 Sagentia (Science Group) Connected Drug Delivery Devices Product Specification
16.6.3 Sagentia (Science Group) Connected Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.7 Cohero Health
16.7.1 Cohero Health Company Profile
16.7.2 Cohero Health Connected Drug Delivery Devices Product Specification
16.7.3 Cohero Health Connected Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.8 Care TRx
16.8.1 Care TRx Company Profile
16.8.2 Care TRx Connected Drug Delivery Devices Product Specification
16.8.3 Care TRx Connected Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.9 CeQur SA
16.9.1 CeQur SA Company Profile
16.9.2 CeQur SA Connected Drug Delivery Devices Product Specification
16.9.3 CeQur SA Connected Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.10 Biocorp Production SA
16.10.1 Biocorp Production SA Company Profile
16.10.2 Biocorp Production SA Connected Drug Delivery Devices Product Specification
16.10.3 Biocorp Production SA Connected Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
17 Connected Drug Delivery Devices Manufacturing Cost Analysis
17.1 Connected Drug Delivery Devices Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Connected Drug Delivery Devices
17.4 Connected Drug Delivery Devices Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Connected Drug Delivery Devices Distributors List
18.3 Connected Drug Delivery Devices Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Connected Drug Delivery Devices (2023-2032)
20.2 Global Forecasted Revenue of Connected Drug Delivery Devices (2023-2032)
20.3 Global Forecasted Price of Connected Drug Delivery Devices (2017-2032)
20.4 Global Forecasted Production of Connected Drug Delivery Devices by Region (2023-2032)
20.4.1 North America Connected Drug Delivery Devices Production, Revenue Forecast (2023-2032)
20.4.2 East Asia Connected Drug Delivery Devices Production, Revenue Forecast (2023-2032)
20.4.3 Europe Connected Drug Delivery Devices Production, Revenue Forecast (2023-2032)
20.4.4 South Asia Connected Drug Delivery Devices Production, Revenue Forecast (2023-2032)
20.4.5 Southeast Asia Connected Drug Delivery Devices Production, Revenue Forecast (2023-2032)
20.4.6 Middle East Connected Drug Delivery Devices Production, Revenue Forecast (2023-2032)
20.4.7 Africa Connected Drug Delivery Devices Production, Revenue Forecast (2023-2032)
20.4.8 Oceania Connected Drug Delivery Devices Production, Revenue Forecast (2023-2032)
20.4.9 South America Connected Drug Delivery Devices Production, Revenue Forecast (2023-2032)
20.4.10 Rest of the World Connected Drug Delivery Devices Production, Revenue Forecast (2023-2032)
20.5 Forecast by Type and by Application (2023-2032)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2023-2032)
20.5.2 Global Forecasted Consumption of Connected Drug Delivery Devices by Application (2023-2032)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Connected Drug Delivery Devices by Country
21.2 East Asia Market Forecasted Consumption of Connected Drug Delivery Devices by Country
21.3 Europe Market Forecasted Consumption of Connected Drug Delivery Devices by Countriy
21.4 South Asia Forecasted Consumption of Connected Drug Delivery Devices by Country
21.5 Southeast Asia Forecasted Consumption of Connected Drug Delivery Devices by Country
21.6 Middle East Forecasted Consumption of Connected Drug Delivery Devices by Country
21.7 Africa Forecasted Consumption of Connected Drug Delivery Devices by Country
21.8 Oceania Forecasted Consumption of Connected Drug Delivery Devices by Country
21.9 South America Forecasted Consumption of Connected Drug Delivery Devices by Country
21.10 Rest of the world Forecasted Consumption of Connected Drug Delivery Devices by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.
}})
Select a license type that suits your business needs
US $3950
Only Three Thousand Nine Hundred Fifty US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
US $4950
Only Four Thousand Nine Hundred Fifty US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
US $5950
Only Five Thousand Nine Hundred Fifty US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI